Sponsor

Birte Glenthoj

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Birte Glenthoj appears in 6 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials6
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

6 shown
Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site CopenhagenNCT01555814 · lead sponsor · 2011-05-01
COMPLETED
The Effect of Sertindole and Risperidone on Endophenotypic Markers of SchizophreniaNCT02021201 · lead sponsor · 2008-07-01
TERMINATED
Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?NCT00206986 · lead sponsor · 2005-05-01
COMPLETED
Neurobiological and Neurocognitive Disturbances in First-episode SchizophreniaNCT00207064 · lead sponsor · 2004-04-01
COMPLETED
The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in SchizophreniaNCT00206947 · lead sponsor · 2002-12-01
TERMINATED
Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode SchizophreniaNCT00206960 · lead sponsor · 1998-01-01
COMPLETED

Sponsor roles

lead sponsor6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.